3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Rectal Neoplasms
2
Breast Neoplasms
2
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Peritoneal Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Oropharyngeal Neoplasms
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Hematologic Diseases
1
Genital Neoplasms, Female
1
Gastrointestinal Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Cholangiocarcinoma
1
Carcinoma in Situ
1
Bone Marrow Diseases
1
Appendiceal Neoplasms
1
Anus Neoplasms
1
Interventions
Rituximab
26
Cyclophosphamide
22
Lenalidomide
21
Prednisone
15
Vincristine
13
obinutuzumab
12
Doxorubicin
12
Magnetic Resonance Spectroscopy
10
Bendamustine Hydrochloride
10
Specimen Handling
8
ibrutinib
7
fludarabine
7
Biopsy
7
Peripheral Blood Stem Cell Transplantation
6
pembrolizumab
5
fludarabine phosphate
5
Whole-Body Irradiation
5
Radiotherapy
5
zanubrutinib
4
venetoclax
4
tazemetostat
4
R-CHOP protocol
4
Prednisolone
4
Mycophenolic Acid
3
Etoposide
3
Cyclosporine
3
tisagenlecleucel
2
polatuzumab vedotin
2
orelabrutinib
2
loncastuximab tesirine
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, Follicular
×
Electrocardiography
×
90 days
×
Clear all
No trials found.